Equities research analysts at Leerink Swann initiated coverage on shares of AC Immune Ltd (NASDAQ:ACIU) in a report released on Tuesday. The firm set an “outperform” rating on the stock.

Other equities research analysts have also issued research reports about the stock. Jefferies Group started coverage on shares of AC Immune in a report on Tuesday. They issued a “buy” rating on the stock. Credit Suisse Group AG began coverage on shares of AC Immune in a research report on Tuesday. They issued an “outperform” rating for the company.

Shares of AC Immune (NASDAQ:ACIU) opened at 14.43 on Tuesday. The firm has a 50-day moving average of $16.17 and a 200-day moving average of $16.17. AC Immune has a 12 month low of $13.01 and a 12 month high of $19.97. The company has a market capitalization of $712.78 million and a P/E ratio of 31.17.

5 Day Chart for NASDAQ:ACIU

Receive News & Stock Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related stocks with our FREE daily email newsletter.